102 On the flip side, a number of teams are advocating for your incorporation of novel markers, such as a sophisticated karyotype55 or epigenetic subsets, 27,28 into clinical follow. Every one of these novel prognostic and/or predictive designs will need to be validated in cohorts of patients treated with focused https://harrye333ark4.wikijournalist.com/user